QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx Supply Disruption — Hospira Inc. (Moderate Risk —
QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx Supply Disruption — Hospira Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx; Manufacturer: Hospira
| Drug name | QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx |
|---|---|
| Manufacturer | Hospira Inc. |
| Recall/Disruption reason | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-315-2013 |
| Initiation date | 20130226 |
| Quantity affected | 139,200 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →